Wall Street can’t expect help from Washington anymore


With its $700 million acquisition of dietary supplement maker NutraNext, Clorox is making a deliberate stride into its newest target market: vitamins, minerals and supplements, CEO Benno Dorer told CNBC on Thursday.

“Two-thirds of the U.S. population use supplements and a lot of consumers, as we age, but also millennials, are looking for a healthier lifestyle and vitamins, minerals,” Dorer told Cramer. “And supplements play an important role and in the future, for us, will form a very important and long-term growth runway.”

Having acquired top probiotics brand Renew Life in 2016, Clorox has been pushing into the niche self-care space for some time. Dorer said that the company has recently started innovating within that space, with the first non-GMO-based Renew Life product in the works.

“We have a dedicated new line for kids … because a lot of moms like to give their kids probiotics to aid with their health and wellness and their digestion, so this is a great growth platform for us,” the CEO said. “We expect it to grow double digits this fiscal year and there’s a lot of growth still to be had on Renew Life for us.”

Source link

Products You May Like

Articles You May Like

Ballooning pot companies are now bigger than Chipotle, Macy’s
GMO’s Catherine LeGraw on emerging markets, trade tensions
‘We expect this is the bottom’ in enterprise growth
Jefferies says AMD could triple its market share due to Intel’s problem
Pot company Aurora Cannabis planning U.S. stock listing next month

Leave a Reply

Your email address will not be published. Required fields are marked *